/

Other

/

Mallinckrodt

Mallinckrodt

Mallinckrodt

Verified Nov 2026

Other

·

United States flag

Chicago, Illinois

·

Since 1867

Mallinckrodt is a specialty pharmaceutical company founded in 1867 and headquartered in Chicago, Illinois, with 1,000–5,000 employees and estimated revenue of $1–5 billion. It develops and manufactures branded specialty pharmaceuticals, generic drugs, active pharmaceutical ingredients, and medical imaging products for autoimmune, rare, and neonatal respiratory conditions. In 2025, the company completed a merger with Endo and a subsequent spin-off, establishing Keenova Therapeutics as its specialty therapeutics platform.

Mallinckrodt

Verified Nov 2026

AT A GLANCE

Founded

1867

Headquarters

United States flag

Chicago, Illinois

Employees

1,000-5,000

Ownership

Mallinckrodt at a glance

Revenue

$1-5B

Est. band

Employees

1,000-5,000

Founded

1867

Headquarters

Chicago, Illinois

Certifications

ISO 13485

Import activity

1408

Industries

Automotive

Electric Vehicles

Medical

Sourcing and import activity

From US customs bill-of-lading records

US sea imports

1408

Named foreign suppliers

41

Top origins

Italy · India · Netherlands · Canada

Chart of the supplier's US import shipment volume trend over time

Shared foreign counterparties do not establish that these companies buy from Mallinckrodt.

What this tells a buyer

The company received approximately 1,408 shipments, with 1,252 originating from its Irish subsidiary and additional supply routes spanning 16 countries including India, Canada, Italy, and the United Kingdom.

Mallinckrodt holds ISO 13485 certification and produces specialty pharmaceuticals, generics, active pharmaceutical ingredients, medical imaging products including technetium-99m for nuclear medicine, and pain management formulations.

The company serves physicians, specialty pharmacies, hospitals, and retail pharmacy chains with treatments for pain management, ADHD, and complex medical conditions across automotive, electric-vehicle, and medical industries.

Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026

STABILITY SIGNALS

Established & active

159 years in operation (founded 1867).

1,408 US import shipments on record.

Holds ISO 13485 certification(s) per public sources.

Overview

Mallinckrodt is a specialty pharmaceutical company founded in 1867 and headquartered in Chicago, Illinois, with 1,000–5,000 employees and estimated revenue of $1–5 billion. It develops and manufactures branded specialty pharmaceuticals, generic drugs, active pharmaceutical ingredients, and medical imaging products for autoimmune, rare, and neonatal respiratory conditions. In 2025, the company completed a merger with Endo and a subsequent spin-off, establishing Keenova Therapeutics as its specialty therapeutics platform.

At a glance

Attribute

Detail

Founded

1867

Headquarters

Chicago, Illinois

Employees

1,000-5,000

Revenue

$1-5B (estimated)

Certifications

ISO 13485

What Mallinckrodt makes

Mallinckrodt holds ISO 13485 certification and produces specialty pharmaceuticals, generics, active pharmaceutical ingredients, medical imaging products including technetium-99m for nuclear medicine, and pain management formulations.

Certifications

Mallinckrodt is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:

Trade and customs footprint

The company received approximately 1,408 shipments, with 1,252 originating from its Irish subsidiary and additional supply routes spanning 16 countries including India, Canada, Italy, and the United Kingdom. US customs bill-of-lading records list 1408 inbound shipments across 41 foreign suppliers, with top origins including Italy · India · Netherlands · Canada.

Latest developments

Company details

The company serves physicians, specialty pharmacies, hospitals, and retail pharmacy chains with treatments for pain management, ADHD, and complex medical conditions across automotive, electric-vehicle, and medical industries. Mallinckrodt was founded in 1867, has an estimated 1,000-5,000 employees, and is headquartered in Chicago, Illinois. On the LightSource stability read it is rated "Established & active": 159 years in operation (founded 1867). 1,408 US import shipments on record. Holds ISO 13485 certification(s) per public sources.

Frequently asked questions

What does Mallinckrodt do?

Mallinckrodt is a specialty pharmaceutical company founded in 1867 and headquartered in Chicago, Illinois, with 1,000–5,000 employees and estimated revenue of $1–5 billion. It develops and manufactures branded specialty pharmaceuticals, generic drugs, active pharmaceutical ingredients, and medical imaging products for autoimmune, rare, and neonatal respiratory conditions. In 2025, the company completed a merger with Endo and a subsequent spin-off, establishing Keenova Therapeutics as its specialty therapeutics platform.

Where is Mallinckrodt headquartered?

Mallinckrodt is headquartered in Chicago, Illinois.

When was Mallinckrodt founded?

Mallinckrodt was founded in 1867.

How big is Mallinckrodt?

Mallinckrodt has an estimated 1,000-5,000 employees, with revenue in the $1-5B range (estimated).

What certifications does Mallinckrodt hold?

Mallinckrodt lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.

Does Mallinckrodt import from overseas suppliers?

US customs bill-of-lading records show 1408 inbound shipments for Mallinckrodt, with top origins including Italy · India · Netherlands · Canada.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Chicago, Illinois (HQ)Headquarters · Illinois, United States
Chicago, Illinois (HQ)Chicago, Illinois, United StatesHeadquarters

Phone

'+1 314-654-3638

Certification

ISO 13485

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.